Profil
Dr. Christophe Thurieau is an Independent Director at Oncodesign Precision Medicine SA and a Chief Executive Officer & Director at Servier Symphogen A/S.
He is on the Board of Directors at Oncodesign Precision Medicine SA and Servier Symphogen A/S.
Dr. Thurieau was previously employed as a Senior Vice President-Scientific Affairs by Ipsen SA. He also served on the board at PregLem SA. He received his undergraduate degree from Harvard University.
Postes actifs de Christophe Thurieau
| Sociétés | Poste | Début |
|---|---|---|
| ONCODESIGN PRECISION MEDICINE | Directeur/Membre du Conseil | 04/03/2025 |
Symphogen A/S
Symphogen A/S BiotechnologyHealth Technology Develops antibody therapeutics for the treatment of cancers | Directeur Général | 04/06/2020 |
Anciens postes connus de Christophe Thurieau
| Sociétés | Poste | Fin |
|---|---|---|
| IPSEN | Corporate Officer/Principal | 01/01/2017 |
PregLem SA
PregLem SA Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products specializing in gynecology and women's reproductive health | Directeur/Membre du Conseil | - |
Formation de Christophe Thurieau
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Ipsen SA
Ipsen SA Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Université Pierre et Marie Curie
Université Pierre et Marie Curie Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
PregLem SA
PregLem SA Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products specializing in gynecology and women's reproductive health | Health Technology |
Symphogen A/S
Symphogen A/S BiotechnologyHealth Technology Develops antibody therapeutics for the treatment of cancers | Health Technology |
Oncodesign Precision Medicine SA
Oncodesign Precision Medicine SA Pharmaceuticals: MajorHealth Technology Discovers and develops new molecules for the health treatments in oncology | Health Technology |
















